1992 related articles for article (PubMed ID: 27608715)
1. Plasma exosome microRNAs are indicative of breast cancer.
Hannafon BN; Trigoso YD; Calloway CL; Zhao YD; Lum DH; Welm AL; Zhao ZJ; Blick KE; Dooley WC; Ding WQ
Breast Cancer Res; 2016 Sep; 18(1):90. PubMed ID: 27608715
[TBL] [Abstract][Full Text] [Related]
2. Exosome-mediated transfer of miR-10b promotes cell invasion in breast cancer.
Singh R; Pochampally R; Watabe K; Lu Z; Mo YY
Mol Cancer; 2014 Nov; 13():256. PubMed ID: 25428807
[TBL] [Abstract][Full Text] [Related]
3. Exosome-mediated microRNA signaling from breast cancer cells is altered by the anti-angiogenesis agent docosahexaenoic acid (DHA).
Hannafon BN; Carpenter KJ; Berry WL; Janknecht R; Dooley WC; Ding WQ
Mol Cancer; 2015 Jul; 14():133. PubMed ID: 26178901
[TBL] [Abstract][Full Text] [Related]
4. Increased number of circulating exosomes and their microRNA cargos are potential novel biomarkers in alcoholic hepatitis.
Momen-Heravi F; Saha B; Kodys K; Catalano D; Satishchandran A; Szabo G
J Transl Med; 2015 Aug; 13():261. PubMed ID: 26264599
[TBL] [Abstract][Full Text] [Related]
5. Presence of Circulating miR-145, miR-155, and miR-382 in Exosomes Isolated from Serum of Breast Cancer Patients and Healthy Donors.
Gonzalez-Villasana V; Rashed MH; Gonzalez-Cantú Y; Bayraktar R; Menchaca-Arredondo JL; Vazquez-Guillen JM; Rodriguez-Padilla C; Lopez-Berestein G; Resendez-Perez D
Dis Markers; 2019; 2019():6852917. PubMed ID: 30891102
[TBL] [Abstract][Full Text] [Related]
6. Circulating microRNAs from the miR-106a-363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer.
Li M; Zhou Y; Xia T; Zhou X; Huang Z; Zhang H; Zhu W; Ding Q; Wang S
Breast Cancer Res Treat; 2018 Jul; 170(2):257-270. PubMed ID: 29557526
[TBL] [Abstract][Full Text] [Related]
7. Malignant canine mammary epithelial cells shed exosomes containing differentially expressed microRNA that regulate oncogenic networks.
Fish EJ; Irizarry KJ; DeInnocentes P; Ellis CJ; Prasad N; Moss AG; Curt Bird R
BMC Cancer; 2018 Aug; 18(1):832. PubMed ID: 30126376
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses in vitro angiogenesis through modulating the mTOR/HIF-1α/VEGF signaling axis in breast cancer cells.
Pakravan K; Babashah S; Sadeghizadeh M; Mowla SJ; Mossahebi-Mohammadi M; Ataei F; Dana N; Javan M
Cell Oncol (Dordr); 2017 Oct; 40(5):457-470. PubMed ID: 28741069
[TBL] [Abstract][Full Text] [Related]
9. Plasma exosome miR-196a and miR-1246 are potential indicators of localized pancreatic cancer.
Xu YF; Hannafon BN; Zhao YD; Postier RG; Ding WQ
Oncotarget; 2017 Sep; 8(44):77028-77040. PubMed ID: 29100367
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-200c and microRNA- 141 are regulated by a FOXP3-KAT2B axis and associated with tumor metastasis in breast cancer.
Zhang G; Zhang W; Li B; Stringer-Reasor E; Chu C; Sun L; Bae S; Chen D; Wei S; Jiao K; Yang WH; Cui R; Liu R; Wang L
Breast Cancer Res; 2017 Jun; 19(1):73. PubMed ID: 28637482
[TBL] [Abstract][Full Text] [Related]
11. Exosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in neighboring peritoneal mesothelial cells.
Yoshimura A; Sawada K; Nakamura K; Kinose Y; Nakatsuka E; Kobayashi M; Miyamoto M; Ishida K; Matsumoto Y; Kodama M; Hashimoto K; Mabuchi S; Kimura T
BMC Cancer; 2018 Nov; 18(1):1065. PubMed ID: 30396333
[TBL] [Abstract][Full Text] [Related]
12. Exosome-encapsulated microRNAs as circulating biomarkers for breast cancer.
Joyce DP; Kerin MJ; Dwyer RM
Int J Cancer; 2016 Oct; 139(7):1443-8. PubMed ID: 27170104
[TBL] [Abstract][Full Text] [Related]
13. Exosome-transmitted long non-coding RNA PTENP1 suppresses bladder cancer progression.
Zheng R; Du M; Wang X; Xu W; Liang J; Wang W; Lv Q; Qin C; Chu H; Wang M; Yuan L; Qian J; Zhang Z
Mol Cancer; 2018 Oct; 17(1):143. PubMed ID: 30285771
[TBL] [Abstract][Full Text] [Related]
14. Exosomal miR-500a-5p derived from cancer-associated fibroblasts promotes breast cancer cell proliferation and metastasis through targeting USP28.
Chen B; Sang Y; Song X; Zhang D; Wang L; Zhao W; Liang Y; Zhang N; Yang Q
Theranostics; 2021; 11(8):3932-3947. PubMed ID: 33664871
[TBL] [Abstract][Full Text] [Related]
15. MicroRNAs in Serum Exosomes as Potential Biomarkers in Clear-cell Renal Cell Carcinoma.
Zhang W; Ni M; Su Y; Wang H; Zhu S; Zhao A; Li G
Eur Urol Focus; 2018 Apr; 4(3):412-419. PubMed ID: 28753793
[TBL] [Abstract][Full Text] [Related]
16. Blood Circulating Exosomes Contain Distinguishable Fractions of Free and Cell-Surface-Associated Vesicles.
Tamkovich S; Tutanov O; Efimenko A; Grigor'eva A; Ryabchikova E; Kirushina N; Vlassov V; Tkachuk V; Laktionov P
Curr Mol Med; 2019; 19(4):273-285. PubMed ID: 30868953
[TBL] [Abstract][Full Text] [Related]
17. Cancer-derived exosomal miR-7641 promotes breast cancer progression and metastasis.
Shen S; Song Y; Zhao B; Xu Y; Ren X; Zhou Y; Sun Q
Cell Commun Signal; 2021 Feb; 19(1):20. PubMed ID: 33618729
[TBL] [Abstract][Full Text] [Related]
18. Circulating exosomal miR-125a-3p as a novel biomarker for early-stage colon cancer.
Wang J; Yan F; Zhao Q; Zhan F; Wang R; Wang L; Zhang Y; Huang X
Sci Rep; 2017 Jun; 7(1):4150. PubMed ID: 28646161
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of circulating miR-25-3p as a novel diagnostic and prognostic biomarker in osteosarcoma.
Fujiwara T; Uotani K; Yoshida A; Morita T; Nezu Y; Kobayashi E; Yoshida A; Uehara T; Omori T; Sugiu K; Komatsubara T; Takeda K; Kunisada T; Kawamura M; Kawai A; Ochiya T; Ozaki T
Oncotarget; 2017 May; 8(20):33375-33392. PubMed ID: 28380419
[TBL] [Abstract][Full Text] [Related]
20. Identification of non-invasive miRNAs biomarkers for prostate cancer by deep sequencing analysis of urinary exosomes.
Rodríguez M; Bajo-Santos C; Hessvik NP; Lorenz S; Fromm B; Berge V; Sandvig K; Linē A; Llorente A
Mol Cancer; 2017 Oct; 16(1):156. PubMed ID: 28982366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]